# Why Arrowhead Shot Sky-High, While Ionis Toppled

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-22 17:29 UTC · Category: Business · Sources: 8 · Current Velocity: 5.66

## Executive Summary
8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

## Intelligence Brief
"Why Arrowhead Shot Sky-High, While Ionis Toppled" is generating significant coverage in the Business category, with 8 articles from 8 distinct sources tracked by Newsylist so far.


Outlets currently covering the story include BioSpace, Yahoo Finance, AlphaStreet and Managed Healthcare Executive. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### Why is "Why Arrowhead Shot Sky-High, While Ionis Toppled" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

### How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

### Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

## Key People, Organizations & Locations
Phase, Highs, Arrowhead, Trials, Ionis, Redemplo, Why Arrowhead Shot Sky-High While Ionis Toppled, Arrowhead's Plozasiran Reduces Triglycerides Pancreatitis Events, ARWR Stock On Track To Hit Over, Retail Cheers Phase

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioSpace | Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug | 2026-07-22 14:05 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMGJISWJWOUUtMWs3RGdDbHVwcG9jaUJ2bGd0OHlNX2g0eXVQV000dDlGVWh2bDdnd2dwcGdZTVhERWlNeUJmRFZpdllocWVMempCWkZhSlpkdGZhMlRnYXZ1WVVvdDBodUdUVXFrbnp5UXU1UnZwY2FmNG1OVXY0OThDTUpNYmdHbTFrc1JDTGxFdGcySG0xdFJjZWxoR1h0MC1nRVBoTm9pd0k4N2FvX204ek0tcEsydVRZQ19fbVBfdw?oc=5) |
| Yahoo Finance | ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval | 2026-07-22 14:05 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPQU9iV0w3NVVyUTYzcEJWZi12Mmx4WHpXYjZzS0FjR1pzUUlEMnd0eHMwZjNFcjRTcUJ0NUJZOE1fVV9SRGFuOUdkX2VNSlJmc3RacmszeFEwVHRPVzBFaVFRdlk5aUJGRlkzX25nNTV2SnU5dzF2SmhwVGxfSFdpWmxDcVFwSHRBRDFFbjN6b1Ixblo4?oc=5) |
| AlphaStreet | Why Arrowhead Pharmaceuticals Is Surging 24.4%: JP Morgan Maintains Overweight | 2026-07-22 14:05 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxNX0tkVzdhMXlfODVqVHhHdGYxcmdVbG93RFctRlZLb2RmT05nWXg0UThmdUJENkd3T3dyZ0hnYkZiWV9tMTRMakREZlloWjJhX0JIM1BBTTFQU2hSYlNFNUhTZVdGV3NOSVV3MHNjMlpwZnoxaWdXWkd6aXVfRlJfNUpmVmd3UlVkVDZKcFZVQTlWdlI1aFF1NEZOTFlOUEQzVS1XS1ViUkRXQdIBqgFBVV95cUxNX0tkVzdhMXlfODVqVHhHdGYxcmdVbG93RFctRlZLb2RmT05nWXg0UThmdUJENkd3T3dyZ0hnYkZiWV9tMTRMakREZlloWjJhX0JIM1BBTTFQU2hSYlNFNUhTZVdGV3NOSVV3MHNjMlpwZnoxaWdXWkd6aXVfRlJfNUpmVmd3UlVkVDZKcFZVQTlWdlI1aFF1NEZOTFlOUEQzVS1XS1ViUkR) |
| Managed Healthcare Executive | Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia | 2026-07-22 13:14 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUDQycjlhYUV2dVRtb1pIczF6aGFlWkZwZjM0MnAzMFo5Y09qV2FyaFppUFdqdnp4M1hSd015QW84MXFKLTVkcWhXSUx2Rkt3Y1RHdnktdHh3bEZCLTVRWGpEdmhiQmxQUHRSaWRmX1YtNW1kNkxzQ3psaTdLZWlJZGlpSGxBMldIZVdsdVVKNl9QRTNFeG4xdGJhV1BTV1V3bWFUSzVkd2taUFRVbGx6MVB4VmhGR1g5dW5DeHhKaFl5QQ?oc=5) |
| BioPharm International | Arrowhead's Plozasiran Reduces Triglycerides, Pancreatitis Events in Phase 3 sHTG Trials | 2026-07-22 13:14 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxPSnFoZW1QdnE2cjQzaWRlTWc2bmpqdzJ6UEZhcWREd3VlN2V6cFJNOG5udzhWNjVydjREUW9EbmtTVDZrV1FCaTJucktJWTE2QW5UXzk5ckotQUtMZmF4RFBIUm9XdnBYUWdsaExnUl9FUGUzeVlFc3B1ZHhSX29FUHB2QXZ0VHd0YnhwN2xmQUxSRE1nRjk3ZHkxdjVpTjEt?oc=5) |
| Seeking Alpha | Ionis drops as Arrowhead posts late-stage trial win for lipid-lowering drug | 2026-07-22 13:14 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxPVUNPWHo3V2djZ3lUbjRHdTJhaUxhZDJuYUdHU1dFWjYxRk9ycVRPVDVKcWZzdHdWWDRoaHJQYVJQZlB1UVF1cmJzNlVMQ213aEpERFJncDJOY2FVMlhvYUNuSHZfZXVDdlhpOGV5UzVJZW5VR1g5NmR0eGZwZXJPbkRNNVdfV1h2bFAtUktR?oc=5) |
| Fierce Pharma | Look out Ionis, here comes Arrowhead with promising hypertriglyceridemia data | 2026-07-22 13:14 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxPVmhnclJ1cVZHV0syajg4cVFhaHM1QUZtNGJEQWt0NE1wOHdRTFF0TVdUbV9GYjNid3ZLbkUxbW9zeUFKSWl5T2xZcVRnaWxXeTJfSkNzWlh2LS11elBOd3NuMDV6RVF6bWd0bmVDWFZ1d3FSTWRVWnlhSGJqRzFzSFhYalBhVFJ2Rmxvb2d1WjN4cm9YTmNKMGt1S0lvR2VHSGNSXzNFeDZaMVBHLXNoT2hJT0I0QQ?oc=5) |
| Investor's Business Daily | Why Arrowhead Shot Sky-High, While Ionis Toppled | 2026-07-22 13:14 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxQM2lPczJrdDBieFVudXZZSy1IZFh6eUd3OU1tenV2VW5Dak1XbEduN1dZWkNSWWJ5bTRMeHMtSEtqSXpzck5nSm96d2dRbDlhZ09kQ2hEc2ZDemJYSnZaQjlJU1h4MkhJa0thNTUtV3hsOEhKT0xYd0h6b3BwT3pvei1LbDFoaVNoNUp6U0Q5U1IzUlR2OEJYUkFyVVRvTTA?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-22/why-arrowhead-shot-sky-high-while-ionis-toppled*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*